Comparison Between Ultrasound-Guided Erector Spinae Plane Block Versus Ultrasound-Guided Caudal Injection - Trial NCT06336161
Access comprehensive clinical trial information for NCT06336161 through Pure Global AI's free database. This phase not specified trial is sponsored by Al-Azhar University and is currently Not yet recruiting. The study focuses on Postoperative Pain. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Al-Azhar University
Timeline & Enrollment
N/A
Apr 01, 2024
May 01, 2025
Primary Outcome
Measurement of Post-operative Pain
Summary
Patient-controlled analgesia is typically used to relieve postoperative pain.
 Patient-controlled analgesia, on the other hand, is prone to opioid-related side effects.
 Furthermore, standard postoperative analgesia has a limited analgesic impact. If
 postoperative lumbosacral spine pain is not successfully treated, it can progress to chronic
 pain, compromising patients' quality of life.
 
 The methods of access for epidural injections are characterized as transforaminal,
 interlaminar, or caudal. Caudal epidural injections (CEI) are often utilized as a diagnostic
 or therapeutic tool in a range of lumbosacral-originating spinal pain problems, and they are
 especially useful in patients with complicated lumbar epidural access diseases, such as post
 laminectomy syndrome. It is regarded as a very simple treatment in the realm of
 interventional pain management, and it is also recognized to have a reduced risk of
 inadvertent Dural puncture than other epidural techniques
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06336161
Non-Device Trial